This protocol is judged by an institutional evaluate board, an impartial team that reviews any scientific trials involving individuals. If a study involves a Timetable I drug, once the board approves the protocol as moral, the researchers need to submit an application for an investigational new drug (IND) variety through the FDA.copyright initiall